HomeIPA • NASDAQ
add
Immunoprecise Antibodies Ltd
Previous close
$0.53
Day range
$0.51 - $0.55
Year range
$0.32 - $2.60
Market cap
14.79M USD
Avg Volume
352.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
5 hours ago
The pullback is half-way over, says strategist who says bull market
continues.
0.55%
0.12%
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | 6.12M | -0.41% |
Operating expense | 6.28M | 8.71% |
Net income | -2.55M | -5.98% |
Net profit margin | -41.68 | -6.41% |
Earnings per share | — | — |
EBITDA | -1.94M | -32.08% |
Effective tax rate | 16.54% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.53M | -41.27% |
Total assets | 59.96M | -20.69% |
Total liabilities | 27.29M | 15.74% |
Total equity | 32.68M | — |
Shares outstanding | 33.53M | — |
Price to book | 0.49 | — |
Return on assets | -11.91% | — |
Return on capital | -14.49% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -2.55M | -5.98% |
Cash from operations | -2.24M | -12,361.11% |
Cash from investing | -65.00K | 79.17% |
Cash from financing | 2.07M | 767.42% |
Net change in cash | -379.00K | 46.54% |
Free cash flow | -1.50M | -484.97% |
About
Founded
1983
Headquarters
Website
Employees
87
